Restored mutant receptor: Corticoid binding in chaperone complexes by trimethylamine N-oxide

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Without a glucocorticoid (GC) ligand, the transcription factor glucocorticoid receptor (GR) is largely cytoplasmic, with its GC-binding domain held in high affinity conformation by a cluster of chaperones. Binding a GC causes serial dis-and re-associations with chaperones, translocation of the GR to the nucleus, where it binds to DNA sites and associates with coregulatory proteins and basic transcription complexes. Herein, we describe the effects of a potent protective osmolyte, trimethylamine N-oxide (TMAO), on a conditions-dependent "activation-labile" mutant GR (GRact/l), which under GR-activating conditions cannot bind GCs in cells or in cell cytosols. In both cells and cytosols, TMAO restores binding to GRact/l by stabilizing it in complex with chaperones. Cells bathed in much lower concentrations of TMAO than those required in vitro show restoration of GC binding, presumably due to intracellular molecular crowding effects.

Figures

  • Fig 1. TMAO restores GR-specific binding of a GC to GRact/l in vitro. (A) Binding of Dex (50 nM, to avoid non-specific binding) in CEM3R43 cell cytosol as a function of TMAO concentration. (B) Dex binding in the presence or absence of 3M TMAO in CEM 3R43 cell cytosol in GR non-activating (4˚) and activating conditions (22˚). Activated, Control vs. 3M TMAO significant at p < 0.013 (paired t-test).
  • Fig 2. Estimating Concentrations of TMAO in the NMR Sample. (A) Establishing tolerable level of TMAO. Culture medium was brought to Final TMAO concentrations shown and cell viability assayed (trypan blue exclusion). (B) 1H-NMR analysis to determine intracellular TMAO levels in cells bathed in medium containing 50mM TMAO. Using a tool in the VNMRJ software, integrals of TMAO peaks were taken in samples and compared to injected DSS reference peak. Molar concentration of TMAO in sample calculated by comparing these two ratios (one of known concentration).
  • Table 1. Cellular concentrations of TMAO.
  • Fig 3. TMAO restores GR-specific binding of a GC to GRact/l in cells. Multi-concentration Dex binding data to specific GR sites in TMAO-bathed cells, plotted by the method of Scatchard. Cellular TMAO concentration was calculated in two waysbased on average protein per cell or average cell volume.
  • Fig 4. Effects of TMAO on GC-driven GR nuclear translocation and loss of cell viability. (A) Loss of cell viability, estimated by water-soluble tetrazolium mitochondrial respiration assay. To maximize effect, cells were treated with 10-6M Dex ±TMAO. “Sham” = electroporation without plasmid; “GR” = wild-type hGR; “L753F” = GRact/l. In this experiment, p < 0.05 (paired t-test) only for TMAO vs TMAO + Dex in GRact/l (L753F) transfected cells (n = 3). (B) Confocal microscopy showing transfected EGFP-GR in nuclei of 3R43 cells after 70nM (to enhance assay sensitivity) Dex treatment. Upper Panel left, clump of cells without, and right, same cells with fluorescence; Lower Panel, cells transfected with EGFP GRact/l. Left, 2 cells in TMAO-supplemented medium, showing cytosolic GR. Right, in TMAO medium plus Dex, a cell showing nuclear GR. Green fluorescence, EGFP fusion GR; red fluorescence, nuclei stained with Draq5.
  • Fig 5. TMAO increases total Dex-GR binding but not % in nuclei. 3R43 cells were transfected with pCMV2 GR(L753F) followed by 50nM H3 Dex (subsaturating concentration, to limit non-specific binding). After their separation, radioactivity in nuclear and cytosolic fractions was determined and molarities calculated from the radioactivity data. The combined nuclear + cytosolic GR was higher in the TMAO-incubated cells (p <0.05, paired t-test, n = 3).
  • Table 2. MMTV-luciferase promoter-reporter activity.
  • Fig 6. TMAO appears to stabilize GRact/l:chaperone complexes. (A) Co-immunoprecipitation (primary antibody to GR) showing the coprecipitation of various known GR chaperones (antibodies specific to the chaperones indicated on right) in 3R43 cell cytosolic extracts. Data from a single blot, equal amounts of protein applied per lane. Lane 1: control extracts (without TMAO); lane 2: cytosolic extracts plus 3M TMAO; and Lane 3: cytosolic extracts from cells treated with 50 mM TMAO and maintained in TMAO throughout. (B) TMAO stabilizes GR:HSP90 complexes in CEM-3R43 and CEM-C7-14 cellular cytosols under both nonactivating (0−40) activating (220) conditions. An immunoadsorption assay was conducted using an anti-GR serum to precipitate the GR:HSP90 complex and blotted against HSP90 antibody. unact = receptor non-activating conditions, act = receptor activating conditions.

References Powered by Scopus

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

18499Citations
N/AReaders
Get full text

Biological and chemical approaches to diseases of proteostasis deficiency

961Citations
N/AReaders
Get full text

How can biochemical reactions within cells differ from those in test tubes?

371Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Gut Microbiota and Cardiovascular Disease

606Citations
N/AReaders
Get full text

TMAO to the rescue of pathogenic protein variants

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Miller, A. L., Austin Elam, W., Johnson, B. H., Khan, S. H., Kumar, R., & Brad Thompson, E. (2017). Restored mutant receptor: Corticoid binding in chaperone complexes by trimethylamine N-oxide. PLoS ONE, 12(3). https://doi.org/10.1371/journal.pone.0174183

Readers over time

‘17‘18‘19‘20‘21‘22‘2300.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Biochemistry, Genetics and Molecular Bi... 2

40%

Agricultural and Biological Sciences 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0